Inaugural National Itch Summit Abstracts
3999:Long-term safety and efficacy (up to 152 weeks) of nemolizumab in ARCADIA open-label long-term extension study in adults and adolescents with moderate-to-severe atopic dermatitis
Jonathan I. Silverberg, Matthias Augustin, Linda Stein Gold, Marjolein de Bruin-Weller, Kim Papp, Dédée Murrell, Franz J. Legat, Antonio Costanzo, Soo Yeon Cheong, Liliana Ulianov, Anna Ryzhkova, Christophe Piketty
4000: Itch-directed therapeutics in hidradenitis suppurativa: a mechanism-based synthesis of an emerging but fragmented evidence base
Kayla D Mashoudy, MD; Yash Jani, BS; Daniela Jaime, BS; Ann Lin, DO
4001: Comparative Efficacy of Topical Therapies for Pruritus in Seborrheic Dermatitis: A Systematic Review and Network Meta-Analysis
Mahnoor gelani; Aman Bakhsh; Iman Khan; Laiba Khan; Hamna Yaseen; Mohamed Hisham Alamin
4006: Staphylococcus aureus protease drives skin barrier disruption and facilitates allergen- induced inflammation
Yanek Jimenez Andrade, Sang Gyu Lee, Jason Gashi, Ethan Arthur Lerner, Jin Mo Park
Page 5 of 5
Results 41 - 44 of 44
Results 41 - 44 of 44